Moscow : A new study by an international team of scientists has revealed conditions under which a body produces more superoxide a dangerous form of oxygen with the capability to destruct DNA.
Human mutations in a gene encoding the DHTKD protein result in a range of neurological disturbances. On molecular level, the mutations cause accumulation of the reactive oxygen species (ROS) and degradation products of lysine and tryptophan, said the study published recently in the journal Free Radical Biology and Medicine.
The structure of the DHTKD protein is similar to an enzyme, 2-oxoglutarate dehydrogenase, which is able to produce superoxide.
According to the researcher, a cell combats the “poisonous” forms of oxygen with a help of antioxidants, and antioxidant defence system proteins.
But disturbed metabolism may cause a shortage of amino acids (the bricks for building proteins) lysine and tryptophan which may result into physical, neurologic and mental malfunctions, and even lead to death.
Those amino acids belong to irreplaceable and cannot be produced from other substances in human body, so they should come from food, the researchers noted.
According to the study, 2-aminoadipate and 2-oxoadipate are the degradation products of lysine, tryptophan and hydroxylysine.
Scientists found the connection between aciduria (increased acidity of urine, showing serious malfunction in metabolism) in patients with increased content of 2-aminoadipate and 2-oxoadipate and gene mutations in the DHTKD protein.
That confirmed an earlier hypothesis that an enzyme, encoded by DHTKD, oxidises 2-oxoadipate.
The DHTKDprotein does not belong to central metabolism and is produced in higher quantities in liver and kidney cells where lysine and tryptophan are more actively degraded. In humans it is degraded in skeletal muscles.
The study found that both the down- and up-regulation of the DHTKD1 expression increased the level of reactive and dangerous forms of oxygen.
Latest posts by supriya kashyap (see all)
- Adenoiditis – GOI Standard Treatment Guidelines - October 25, 2018
- Chronic Laryngitis – GOI Standard Treatment Guidelines - October 23, 2018
- Wilms tumour- GOI Standard Treatment Guidelines - October 22, 2018